Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS

The COVID-19 pandemic caused by the novel SARS-CoV-2 is more contagious than other coronaviruses and has higher rates of mortality than influenza. As no vaccine or drugs are currently approved to specifically treat COVID-19, identification of effective therapeutics is crucial to treat the afflicted...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Donovan, Sinead M, Eby, Hunter, Henkel, Nicholas D, Creeden, Justin, Imami, Ali, Asah, Sophie, Zhang, Xiaolu, Wu, Xiaojun, Alnafisah, Rawan, Taylor, R. Travis, Reigle, James, Thorman, Alexander, Shamsaei, Behrouz, Meller, Jarek, McCullumsmith, Robert E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336712/
https://www.ncbi.nlm.nih.gov/pubmed/32702077
http://dx.doi.org/10.21203/rs.3.rs-25643/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336712/
https://www.ncbi.nlm.nih.gov/pubmed/32702077
http://dx.doi.org/10.21203/rs.3.rs-25643/v1

Ejemplares similares